Daily insulin dose and incidence of hypoglycemia in children with type 1 Diabetes using insulin pump therapy

被引:0
作者
Hasanbegovic, S. [1 ]
Hasanbegovic, E. [1 ]
机构
[1] Univ Sarajevo, Ctr Clin, Pediat Clin, Sarajevo 71000, Bosnia & Herceg
来源
HEALTHMED | 2009年 / 3卷 / 02期
关键词
TYPE 1 Diabetes Mellitus; insulin pump; insulin dose; hypoglycaemia; children; INFUSION CSII; ADOLESCENTS; INJECTIONS; CARE; STATEMENT; YOUTH; AGE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In retrospective study followed all TYPE 1 Diabetes mellitus (T1DM) patients with insulin pump (IP) therapy started in the period from the 1(st) March 2005 to the 1(st) September 2008. We analyzed: age and sex structure of the observed patients; their therapy before IP use; total daily insulin dose during 6 months before and during 6 months after IP therapy introduced; incidence of severe hypoglycaemic episodes during 6 months before and during 6 months after IP therapy start. The total number of observed patients was 39. There were 24 boys (61,5 %) and 15 girls (38,5 %) with the age range between 12,3 +/- 3,2 years. Most patients were from age group 8-14 years. Be e IP introduction most patient 61,5 % use therapy with insulin analogues. Mean daily insulin do e during 6 months before IP therapy was 0,96 +/- 0,12 IU/kg of body weight, and during 6 months long IP therapy was 0,61 +/- 0,07 IU/kg ( p =0,0044). Before IP therapy start severe hypoglycemia episodes occurred in 15 patients and after IP therapy in 2 patients. Frequency of severe hypoglycemic episodes decreased from 0,38 to 0,05 per patient. Incidence of severe hypoglycemic episodes was before LP start 0,82/patient/year and after IP start was 0, 10/patient/year ( p<0,001). Therapy with IP in children with diabetes was very efficient in decreasing daily insulin dose and in significant decrease incidence of severe hypoglycemic episodes what would result in less variability of glycemia and in better metabolic control of the disease.
引用
收藏
页码:142 / 148
页数:7
相关论文
共 23 条
  • [1] BATTELINO T, 2007, INSULINSKA CRPALKA R, P45
  • [2] Insulin pump therapy in the 21st century - Strategies for successful use in adults, adolescents, and children with diabetes
    Bode, BW
    Tamborlane, WV
    Davidson, PC
    [J]. POSTGRADUATE MEDICINE, 2002, 111 (05) : 69 - 77
  • [3] Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy
    Bruttomesso, Daniela
    Costa, Silvana
    Baritussio, Aldo
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2009, 25 (02) : 99 - 111
  • [4] Childs BP, 2005, DIABETES CARE, V28, P1245
  • [5] Comparison between continuous subcutaneous insulin infusion and multiple daily injection regimens in adolescent with type 1 diabetes from a public health care system approach to severe hypoglycemia
    Gabbay, Monica A. L.
    Dib, Sergio A.
    [J]. ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2007, 51 (07) : 1169 - 1174
  • [6] HALLER MJ, 2007, PEDIAT ENDOCRINOLOGY, P66
  • [7] Hanas R, 2006, PEDIATR DIABETES, V7, P25, DOI 10.1111/j.1399-543X.2006.00145.x
  • [8] Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years
    Jakisch, B. I.
    Wagner, V. M.
    Heidtmann, B.
    Lepler, R.
    Holterhus, P-M.
    Kapellen, T. M.
    Vogel, C.
    Rosenbauer, J.
    Holl, R. W.
    [J]. DIABETIC MEDICINE, 2008, 25 (01) : 80 - 85
  • [9] Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis
    Jeitler, K.
    Horvath, K.
    Berghold, A.
    Gratzer, T. W.
    Neeser, K.
    Pieber, T. R.
    Siebenhofer, A.
    [J]. DIABETOLOGIA, 2008, 51 (06) : 941 - 951
  • [10] Characteristics of adolescents with type 1 diabetes who exhibit adverse outcomes
    Johns, Carla
    Faulkner, Melissa Spezia
    Quinn, Lauretta
    [J]. DIABETES EDUCATOR, 2008, 34 (05) : 874 - 885